Local Institution - 0097 — Portsmouth, New Hampshire

Local Institution - 0097 is a clinical research site located in Portsmouth, New Hampshire, United States 03801.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 0097 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Plaque Psoriasis.

Sponsors: Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Portsmouth

Browse all research sites in New Hampshire · View every site in Portsmouth

• Portsmouth Regional Hospital Hematology/Oncology Clinic
• Portsmouth Regional Hospital
• Portsmouth Regional Hospital; Hem/Onc Clinic
• ActivMed Practices & Research
• Allcutis Research
• ActivMed Practices and Research
• Research Site
• Eyesight Ophthalmic Services, PA
• Stracskin
• Seacoast Kidney and Hypertension Specialists
• Excellent Vision
• Galderma Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0097?

Local Institution - 0097 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0097 conducted?

Local Institution - 0097 has 1 clinical trials on record, with 1 currently active. Their work covers Plaque Psoriasis.

Is Local Institution - 0097 accredited by Crixeo Clinical Trials?

Local Institution - 0097 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0097?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.